28th November – Falsified Medicines Directive (FMD) and Quality Payments event
28th November 2018 6.30 for 7.15pm
North Staffs Medical Institute Hartshill road Newcastle
The LPC would like to invite you to a training session on two important topics. Firstly, Falsified Medicines Directive (FMD) 2011/62/EU, published on the 9 February 2016, will come in to force by February 2019. Falsified medicines are “fake” medicines that pass themselves off as real, authorised medicines.
From 9th February 2019, market authorisation holders are required to place two safety features on all new packs of prescription medicines placed on the market in Europe:
- a unique identifier (UI) in the form of a 2D data matrix (barcode) which can be scanned at various points along the supply chain to determine its authenticity; and
- an anti-tamper device (ATD).
In order to comply with the requirements of FMD, pharmacy contractors will be required as part of the dispensing process (from 9th February 2019 and for products that bear safety features) to:
- check the anti-tampering device (ATD) to ensure it is intact prior to dispensing; and
- change the status of the pack in the UK’s National Medicines Verification System from “active” to “inactive—supplied”. This involves scanning the 2D barcode on each pack and communicating with the National Medicine Verification System (NMVS).
Secondly, Quality payments – In September 2018, a new Quality Payments Scheme was announced for the remainder of the 2018/19 financial year. The new scheme has a review point in February 2019 and several revisions from previous scheme criteria.
Key speakers from the NPA will be helping contractors and their staff to implement these to important changes in pharmacy.
Date: 28th November 2018
Venue: North Staffs Medical Institute, Hartshill Road, Newcastle ST4 7NY
Time: 6.30pm for food and drink, 7.15pm -9.15pm training session
To attend this training session please book on using the form below